Apg Asset Management N.V. Dexcom Inc Transaction History

Apg Asset Management N.V.

$38.2 Billion
Q2 2025

A detailed history of Apg Asset Management N.V. transactions in Dexcom Inc stock. As of the latest transaction made, Apg Asset Management N.V. holds 234,798 shares of DXCM stock, worth $16 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

234,798

Previous 227,347 3.28%

Holding current value

$16 Million

Previous $15.5 Million 32.01%

% of portfolio

0.05%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$59.83 - $87.57 $445,793 - $652,484	7,451 Added 3.28%	234,798 $20.5 Million
Q1 2025 May 14, 2025	SELL	$67.74 - $90.75 $1.1 Million - $1.47 Million	-16,235 Reduced 6.67%	227,347 $15.5 Million
Q4 2024 Feb 13, 2025	BUY	$65.68 - $81.01 $13.6 Million - $16.8 Million	207,601 Added 576.97%	243,582 $18.9 Million
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $17.5 Million - $31.7 Million	-273,519 Reduced 88.37%	35,981 $2.41 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $1.91 Million - $2.43 Million	17,302 Added 5.92%	309,500 $35.1 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $3.08 Million - $3.78 Million	-26,978 Reduced 8.45%	292,198 $40.5 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $362,050 - $595,471	-4,796 Reduced 1.48%	319,176 $39.6 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $5.83 Million - $9.35 Million	-67,768 Reduced 17.3%	323,972 $30.2 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $3.41 Million - $3.97 Million	30,295 Added 8.38%	391,740 $50.3 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $6.59 Million - $7.79 Million	-63,402 Reduced 14.92%	361,445 $42 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $29.8 Million - $43 Million	350,481 Added 471.29%	424,847 $48.1 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $1.85 Million - $2.28 Million	24,218 Added 48.29%	74,366 $6.11 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $3.1 Million - $6.07 Million	45,644 Added 1013.41%	50,148 $3.58 Million
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $611,520 - $846,299	-6,500 Reduced 59.07%	4,504 $2.07 Million
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $389,610 - $488,460	-3,000 Reduced 21.42%	11,004 $5.2 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $416,169 - $558,402	-3,900 Reduced 21.78%	14,004 $6.61 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $147,401 - $196,432	1,820 Added 11.32%	17,904 $6.45 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $3.31 Million - $4.09 Million	-39,004 Reduced 70.8%	16,084 $4.92 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $1.36 Million - $1.82 Million	-17,390 Reduced 23.99%	55,088 $16.6 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $2.11 Million - $2.49 Million	-22,041 Reduced 23.32%	72,478 $25.5 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $2.19 Million - $3.67 Million	-34,869 Reduced 26.95%	94,519 $34.1 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $5.53 Million - $8.76 Million	115,788 Added 851.38%	129,388 $34.8 Million
Q1 2020 May 14, 2020	SELL	$47.79 - $75.63 $5.04 Million - $7.98 Million	-105,469 Reduced 88.58%	13,600 $1.44 Million
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $1.14 Million - $1.78 Million	31,100 Added 35.35%	119,069 $23.2 Million
Q3 2019 Nov 08, 2019	BUY	$35.53 - $43.8 $2.35 Million - $2.9 Million	66,269 Added 305.39%	87,969 $12 Million
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $225,504 - $315,252	8,100 Added 59.56%	21,700 $2.86 Million
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $367,064 - $508,231	13,600 New	13,600 $1.43 Million
Q4 2017 Jan 24, 2018	SELL	$11.12 - $15.38 $195,712 - $270,688	-17,600 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$11.36 - $18.98 $199,936 - $334,048	17,600	17,600 $861,000

Others Institutions Holding DXCM

# of Institutions

1,109

Shares Held

367M

Call Options Held

5.36M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Dexcom Inc Transaction History